Antibiotic

Mycinamicin V is an ester peptide antibiotic that targets bacterial protein synthesis. It exhibits significant antibacterial activity against Gram-positive bacteria, making it a valuable compound for research in microbiology and infectious disease studies. Mycinamicin V is utilized in the investigation of bacterial resistance mechanisms and the development of new antimicrobial therapies.

LBM-415 is a peptide deformylase (PDF) inhibitor with demonstrated antibacterial activity against antimicrobial-resistant gram-positive cocci. It exhibits a minimum inhibitory concentration (MIC90) range of 0.12-8 µg/ml, indicating its potency in inhibiting bacterial growth. Additionally, the inhibition of efflux pump activity may enhance the sensitivity of bacteria to LBM-415, thereby improving its overall antibacterial efficacy. This compound serves as a valuable tool for research into antibiotic resistance and the development of novel therapeutic strategies.

Napyradiomycin A2 is an antibiotic that targets Gram-positive bacteria and exhibits significant mycobacterial activity. Its mechanism of action involves the interference with bacterial cell wall synthesis, making it a valuable tool in the study of antibiotic resistance and the development of novel therapeutic agents. This compound is suited for research applications in microbiology and drug discovery, particularly in the context of mycobacterial infections such as tuberculosis.

Sakyomicin B is a benzoquinone antibiotic that targets Gram-positive bacteria and mycobacteria. Isolated from the strain of Nocardia sp. M-53, it exhibits potent antimicrobial properties, making it valuable for research into bacterial infections and antibiotic resistance. Its unique mechanism and efficacy in combating specific bacterial strains highlight its significance in the field of microbiology and pharmacology.

Bicyclomycin is an antibiotic that targets bacterial RNA polymerase, inhibiting bacterial transcription. It exhibits selective antibacterial activity against Gram-negative bacteria, including Escherichia coli and Klebsiella species, without cross-resistance. Bicyclomycin is valuable for research focusing on infectious diseases and the mechanisms of antibiotic resistance.

Arugomycin is an anthracycline antibiotic primarily targeting Gram-positive bacteria. Its mechanism of action involves intercalation into DNA, which also suggests potential as an antitumor agent. This compound is valuable for research in antibiotic resistance and cancer therapeutics.

Fluvirucin B3 is an antibiotic that targets the influenza A virus. It has demonstrated significant antiviral activity, making it a valuable compound for research focused on influenza infections. Its application in laboratory studies provides insights into the mechanisms of viral resistance and aids in the development of novel therapeutic strategies against influenza A virus.

Epoxyquinomicin D is a potent antibiotic derived from Amycolatopsis sp., primarily targeting bacterial pathogens. It demonstrates notable anti-inflammatory properties, particularly in models of collagen-induced arthritis. This compound is valuable in research focused on antibiotic efficacy and the modulation of inflammatory processes in autoimmune conditions.

1,5-Dideoxy-1,5-imino-D-mannitol is an antibiotic that exhibits antibacterial properties through its action on bacterial cell wall synthesis. This compound is valuable for research aimed at understanding bacterial resistance mechanisms and the development of new antibacterial agents. Its specific activity against various bacterial strains makes it an important tool in antimicrobial studies.

Cefoxazole is a β-lactam antibiotic that contains an isoxazole moiety, primarily targeting bacterial cell wall synthesis. It exhibits significant antibacterial activity against a range of Gram-positive and Gram-negative organisms. Cefoxazole is applicable in research related to the treatment and study of infectious diseases, particularly in evaluating its efficacy against resistant strains.

Emerin is an antibiotic derived from the fungal strain Aspergillus nidulans. It exhibits potent antibacterial activity, primarily targeting bacterial ribosomes to inhibit protein synthesis. Emerin has valuable applications in microbiological research and the study of bacterial resistance mechanisms.

Actinobolin is an antibiotic that primarily inhibits protein synthesis by targeting both bacterial and eukaryotic ribosomes. Demonstrating effective antibacterial activity, Actinobolin exhibits IC50 values of 19.2 μmol/L against Mycobacterium smegmatis, 27.9 μmol/L against Escherichia coli, and 288 μmol/L against rabbit reticulocyte lysate (RRL). This compound is valuable for research applications focused on protein synthesis inhibition and antimicrobial activity studies.

Chrymutasin B is a glycosidic antibiotic with potent cytotoxic properties. Its primary mechanism involves inhibiting cellular proliferation, making it a valuable tool for antitumor research. Chrymutasin B is utilized in studies focused on cancer therapeutics and the exploration of antibiotic efficacy against cancer cell lines.

Minimycin, also known as Oxazinomycin, is an antitumor antibiotic targeting a variety of cancer cell lines. It exhibits broad-spectrum antibacterial activity and has demonstrated significant inhibitory effects against mouse Ehrlich ascites carcinoma, as well as both ascitic and solid forms of sarcoma-180. This compound is particularly valuable for research in oncology and antimicrobial studies.

2'-Amino-2'-deoxyadenosine is a nucleoside antibiotic known for its ability to inhibit various strains of Mycoplasma. By targeting the synthesis pathways within these microorganisms, it demonstrates significant antibacterial activity. This compound is widely employed in research applications focused on studying bacterial infections and developing novel therapeutic strategies against Mycoplasma-related diseases.

Noboritomycins B is a polyether antibiotic that exerts potent activity against Gram-positive bacteria. It demonstrates effectiveness in inhibiting bacterial growth, making it valuable for studies focused on bacterial infections. Additionally, Noboritomycins B exhibits a weak anti-coccidial effect, providing insights into its potential applications in parasitic research.

Pneumocandin A2 is a lipopeptide antibiotic that primarily targets the synthesis of 1,3-β-glucan, an essential component of fungal cell walls. This compound exhibits potent anti-Candida activity with an IC50 value ranging from 0.07 to 0.5 µg/mL in vitro, making it a valuable tool for studying fungal infections. Pneumocandin A2 is utilized in research focused on antifungal mechanisms and the development of therapeutic interventions against Candida species.

Everninomicin D is a potent antibiotic targeting Gram-positive bacteria. It exhibits significant antibacterial activity, making it a valuable tool for research involving bacterial infections and the study of antibiotic resistance mechanisms. Its unique mechanism of action allows for exploration in the development of new antimicrobial therapies.

Neomycin F is an aminoglycoside antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits broad-spectrum antimicrobial activity against Gram-positive and Gram-negative bacteria, as well as mycobacteria and certain protozoa. Neomycin F is particularly effective in treating infections such as amebic dysentery and select cases of bacillary dysentery, making it a valuable reagent in microbiological research and pharmaceutical applications.

N(5)-Hydroxy-L-arginine is an antibiotic that exerts its activity against both Gram-positive and Gram-negative bacteria. This compound is valuable for research focused on bacterial inhibition and exploring mechanisms of antibiotic resistance. Its unique structure and function make it an essential reagent for investigating antibacterial therapeutic strategies.

DC-86-M is an antibiotic derived from the bacterium Streptomyces luteogriseus, known for its potent antibacterial properties. It demonstrates antibacterial activity against various strains, including Bacillus subtilis, Staphylococcus aureus, Enterococcus faecalis, Vibrio anguillarum, and Proteus vulgaris, with a minimum inhibitory concentration (MIC) of less than 1 μg/mL. Additionally, DC-86-M has shown antitumor effects against mouse sarcoma 180, exhibiting a lethal dose (LD50) of 25 mg/kg. This reagent can be utilized in studies involving antibiotic efficacy and cancer research.

Monamycin G1 is an ester peptide antibiotic that primarily targets Gram-positive bacteria. It exhibits significant antibacterial activity, making it a valuable tool for microbiological research. This compound can be utilized in studies involving bacterial resistance mechanisms and the development of new therapeutic agents against Gram-positive infections.

Sesquicillin A is an insecticidal antibiotic that serves as a fungal metabolite derived from white plantain. It is effective in inhibiting the growth of Artemia salina brine shrimp, demonstrating a minimal inhibitory concentration (MIC) of 6.25 µg/mL. This compound is valuable for research applications focused on entomology and the development of biopesticides.

Pluracidomycin D is a carbapenem antibiotic that targets a broad range of bacterial pathogens. It exhibits significant antibacterial activity against both Gram-positive and Gram-negative bacteria, making it a valuable tool in microbiological research and antibiotic development. Its unique mechanism of action contributes to its effectiveness in combating bacterial resistance, paving the way for potential therapeutic applications.

Gentamicin A is an antibiotic that targets a broad spectrum of Gram-positive and Gram-negative bacteria. It exhibits significant antibacterial activity, particularly against methicillin-sensitive Staphylococcus species. This compound is widely utilized in microbiological research to study bacterial resistance mechanisms and to evaluate antibiotic efficacy in clinical and laboratory settings.

Pyrrocidine A is an antibiotic that exhibits notable antibacterial activity, derived from LL-Cyan426. This compound targets various bacterial strains, making it a valuable reagent for research focused on bacterial infections and antibiotic development. Its unique mechanism of action offers potential insights into novel therapeutic strategies against antibiotic-resistant pathogens.

Monamycin D1 is an ester peptide antibiotic that targets Gram-positive bacteria. This compound exhibits potent antibacterial activity, making it a valuable tool for research applications focused on bacterial pathogenesis and antibiotic resistance. Its efficacy in inhibiting Gram-positive strains provides insights into antibiotic mechanisms and potential therapeutic strategies.

Cervicarcin is an antitumor antibiotic that predominantly targets cancerous cells through its potent inhibitory action. It exhibits significant cytotoxicity against sarcoma 180 and sarcoma NF, while demonstrating a lesser impact on sarcoma 37, Ehrman's ascites cancer, and Friend leukemia. This compound is valuable for research applications focused on investigating tumor biology and evaluating therapeutic strategies for various sarcomas.

Memnobotrin A is an antitumor antibiotic derived from Memnoniella echinata (JS6308). This compound exhibits significant inhibitory effects on various cancer cell lines, including NCI-460, MCF7, and SF-268. It serves as a valuable tool for research applications focused on elucidating mechanisms of cancer cell growth and resistance.

Pluracidomycin C3 is a carbapenem antibiotic that exhibits potent activity against both Gram-positive and Gram-negative bacteria. This compound disrupts bacterial cell wall synthesis, making it a valuable tool in the study of antibiotic resistance mechanisms. Its efficacy in various bacterial models supports its use in researching novel antimicrobial therapies and evaluating susceptibility patterns in pathogenic strains.

2-Hydroxygentamicin B is a 3 aminoglycoside antibiotic that exerts its action by inhibiting bacterial protein synthesis. It demonstrates significant antibacterial activity against both Gram-positive and Gram-negative bacteria. This compound is used in microbiological research to explore mechanisms of antibiotic resistance and the efficacy of various treatment regimens.

Tobramycin (monosulfate) is a broad-spectrum aminoglycoside antibiotic primarily targeting bacterial ribosomes to inhibit protein synthesis. It exhibits potent antibacterial activity against a range of gram-negative bacteria, particularly Pseudomonas aeruginosa, making it valuable in the treatment of moderate to severe infections. Tobramycin monosulfate is commonly utilized in research to investigate pneumonia and other infections caused by susceptible organisms.

Asparenomycin A is a carbapenem antibiotic that effectively inhibits β-lactamase enzymes. This compound demonstrates potent antibacterial activity, making it valuable for research into antibiotic resistance and the development of novel therapeutic strategies. Its mechanism of action and strong efficacy against resistant bacterial strains support its application in microbiological studies and drug development initiatives.

Nanaomycin D is an antibiotic that targets bacterial cell processes to exert its antibacterial activity. It effectively inhibits the growth of various bacterial strains, making it a valuable tool for microbiological studies. Researchers can use Nanaomycin D to investigate bacterial resistance mechanisms and the efficacy of antimicrobial agents in treating bacterial infections.

Coumamidine γ1 is a potent alkaline sugar antibiotic that targets bacterial cell wall synthesis. It exhibits broad-spectrum antibacterial activity, including significant efficacy against Pseudomonas aeruginosa. This compound is valuable for research applications focused on combating antibiotic-resistant pathogens and studying bacterial resistance mechanisms.

8-Hydroxyerythromycin A is a semi-synthetic antibiotic primarily targeting bacterial infections. This compound exhibits significant antibacterial activity, making it valuable in the study of mechanisms of antibiotic resistance and in the development of new therapeutic strategies. It is applicable in various research fields, including microbiology and pharmacology, where understanding antibiotic efficacy is essential.

Ibafloxacine is a fluoroquinolone antibiotic designed primarily for veterinary applications. It functions by inhibiting bacterial DNA gyrase and topoisomerase IV, leading to the disruption of DNA replication and transcription in susceptible organisms. Its key biological activity includes effective treatment against various bacterial infections in animals, making it a valuable tool for veterinary medicine research and development.

Tigemonam is a monobactam antibiotic that targets β-lactamase enzymes, demonstrating a Ki of 0.86 μM against Enterobacter cloacae P99 and 50.8 μM against Escherichia coli TEM-1. It binds to penicillin-binding proteins 1a, 3, and 4, effectively inhibiting bacterial cell wall synthesis and exhibiting bactericidal activity against a range of aerobic gram-negative bacteria, including Enterobacteriaceae, Haemophilus influenzae, and Neisseria gonorrhoeae. Tigemonam is resistant to hydrolysis by multiple β-lactamases and has been shown to reduce bacterial load in systemic and localized infections in rodent models. This compound is valuable for research into gram-negative bacterial infections, particularly acute pyelonephritis, lung infections, and thigh muscle infections.

Tauroxicum is an antibiotic substitute that functions as a non-toxic, non-antimicrobial agent. It has been shown to enhance the health, productivity, feed efficiency, and weight gain of livestock animals. This reagent serves as a valuable tool in animal husbandry, offering a means to support livestock welfare while potentially reducing reliance on traditional antibiotics.

PK150, an analogue of Sorafenib, is an antibiotic that demonstrates oral bioavailability and effective antibacterial activity against multiple pathogenic bacterial strains at submicromolar concentrations. Notably, PK150 exhibits inhibitory effects on Gram-positive bacteria, including Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), and Vancomycin intermediate Staphylococcus aureus (VISA), with minimum inhibitory concentrations (MICs) of 0.3 μM for MSSA and 0.3-1 μM for MRSA and VISA. This compound is suitable for research applications aimed at understanding bacterial resistance and developing novel antimicrobial therapies.

Cefditoren is an orally active antibiotic that exhibits broad-spectrum antibacterial activity against both Gram-negative and Gram-positive bacteria. It demonstrates a MIC50 of 0.25-0.5 mg/L against Streptococcus pneumoniae strains. Cefditoren is primarily utilized in the treatment of respiratory tract infections and skin infections, making it a valuable tool in infectious disease research.

Cadrofloxacin is an orally active fluoroquinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV, leading to inhibition of bacterial DNA replication. It demonstrates efficacy against a wide range of both aerobic and anaerobic Gram-positive and Gram-negative bacteria. This compound is useful for research applications focused on combating infectious diseases and studying bacterial resistance mechanisms.

LpxH-IN-AZ1 is a sulfonyl piperazine compound that functions as a potent inhibitor of UDP-2,3-diacylglucosamine pyrophosphate hydrolase (LpxH). This compound demonstrates significant inhibitory activity against Klebsiella pneumoniae LpxH, achieving an IC50 value of 0.36 μM. LpxH-IN-AZ1 is valuable for research applications targeting antibiotic drug development and bacterial resistance mechanisms.

Sulfanitran is a sulfonamide antibiotic that serves as an antibacterial and anticoccidial agent, particularly in poultry feed formulations. This compound functions as a stimulator of multidrug resistance protein 2 (MRP2), enhancing its affinity for estradiol-17-β-D-glucuronide (E217βG). It is utilized in research applications focused on antibiotic resistance and the modulation of drug transport mechanisms.

LAH4 is an amphipathic peptide antibiotic characterized by its alpha-helical structure. It demonstrates potent antimicrobial properties, along with effective nucleic acid transfection and enhanced cell penetration capabilities. LAH4 shows a strong affinity for anionic lipids present in the outer membranes of bacteria, making it a valuable tool for plasmid DNA delivery in various research applications.

Sulfadiazine-d4 is a deuterium-labeled variant of the sulfonamide antibiotic sulfadiazine, which primarily targets dihydropteroate synthase to inhibit bacterial folate synthesis. This compound is utilized in research applications involving the investigation of sulfonamide pharmacokinetics, metabolism, and its effects on bacterial infection models, particularly toxoplasmosis. The stable isotope labeling allows for enhanced monitoring and analysis in various biochemical assays.

Cefaloglycin is a nephrotoxic β-lactam cephalosporin antibiotic that exhibits significant antibacterial activity, specifically targeting Gram-positive cocci, excluding enterococci. Its mechanism involves inhibition of bacterial cell wall synthesis, making it effective in clinical settings requiring treatment of specific bacterial infections. Additionally, Cefaloglycin has been shown to interfere with mitochondrial substrate uptake and respiration, adding to its profile as a compound of interest in biochemical and pharmacological research.

Micrococcin P1 is a macrocyclic peptide antibiotic exhibiting significant antiviral and antibacterial activity. Its primary mechanism involves the inhibition of hepatitis C virus (HCV) replication, with an EC50 range of 0.1-0.5 μM. Additionally, Micrococcin P1 demonstrates in vitro antibacterial efficacy against Gram-positive bacteria, with MIC values of 2 μg/mL for Staphylococcus aureus, 1 μg/mL for Enterococcus faecalis, and 1 μg/mL for Streptococcus pyogenes. Furthermore, it is an effective inhibitor of the malaria parasite Plasmodium falciparum, making it valuable for diverse research applications in infectious diseases.

Malacidin B is a macrocyclic lipopeptide antibiotic that exerts its antibacterial effects through a calcium-dependent mechanism. It has demonstrated significant activity against a range of Gram-positive bacteria, making it a valuable tool for researchers studying antibiotic resistance and developing new antimicrobial therapies. Its unique structure and mechanism of action provide avenues for exploring novel treatments in bacterial infections.

M 14659 is a semisynthetic cephalosporin antibiotic with potent antimicrobial activity. It exhibits strong inhibitory effects against Gram-negative bacteria, notably Pseudomonas aeruginosa. This compound is applicable in research focused on antibiotic resistance and the development of novel therapeutic strategies for bacterial infections.